Biostatistics Practice Questions

Q: A city has a population of 10000 with 500 diabetic patients. A new diagnostic test gives true positive results in 350 patients and false positive results in 1900 patients. Which of the following is/are true regarding the test?

All of the above. To solve this problem, we must first organize the given data into a **2x2 contingency table**. * **Total Population (N):** 10,000 * **Disease Present (Diabetics):** 500 * **Disease Absent (Non-diabetics):** 10,000 - 500 = 9,500 * **True Positives (TP):** 350 * **False Positives (FP):** 1,900 ### Step-by-Step Calculation: 1. **Prevalence:** This is the proportion of the population that has the disease at a specific point in time. * Formula: (Total cases / Total population) × 100 * Calculation: (500 / 10,000) × 100 = **5%**. (**Option A is correct**) 2. **Sensitivity:** The ability of a test to correctly identify those with the disease (True Positive Rate). * Formula: [TP / (TP + FN)] × 100. Since (TP + FN) equals the total diseased (500): * Calculation: (350 / 500) × 100 = **70%**. (**Option B is correct**) 3. **Specificity:** The ability of a test to correctly identify those without the disease (True Negative Rate). * First, find True Negatives (TN): Total Non-diabetics - False Positives = 9,500 - 1,900 = 7,600. * Formula: (TN / Total Non-diabetics) × 100 * Calculation: (7,600 / 9,500) × 100 = **80%**. (**Option C is correct**) Since all individual calculations match the options provided, **Option D (All of the above)** is the correct answer. ### NEET-PG High-Yield Pearls: * **Sensitivity** is used for **Screening** (SnNout: Sensitivity rules OUT disease). * **Specificity** is used for **Confirmation** (SpPin: Specificity rules IN disease). * **Prevalence** affects Predictive Values (PPV/NPV) but does **not** change Sensitivity or Specificity, which are inherent properties of the test.

Q: Which of the following is NOT true about the normal response curve?

Standard deviation = 0. ### Explanation The **Normal Distribution Curve** (also known as the Gaussian distribution) is a fundamental concept in biostatistics used to describe how continuous biological variables (like height, blood pressure, or Hb levels) are distributed in a population. **Why Option C is the correct answer:** In a normal distribution, the **Standard Deviation (SD) cannot be zero**. The SD represents the "spread" or dispersion of data around the mean. If the SD were 0, every single observation in the dataset would be identical to the mean, resulting in a single vertical line rather than a curve. In a **Standard Normal Distribution**, the Mean is 0 and the **Standard Deviation is 1**. **Analysis of Incorrect Options:** * **Option A (Bell-shaped):** This is a defining characteristic. The curve is perfectly symmetrical around the center; the left half is a mirror image of the right half. * **Option B (Total area = 1):** In probability theory, the total area under the normal curve represents the total probability of all possible outcomes, which is always equal to 1 (or 100%). * **Option D (Mean, Median, and Mode coincide):** Because the curve is perfectly symmetrical and unimodal, the peak (Mode), the middle value (Median), and the average (Mean) all fall at the exact same central point. **High-Yield Clinical Pearls for NEET-PG:** * **Empirical Rule (68-95-99.7 Rule):** * Mean ± 1 SD covers **68.3%** of values. * Mean ± 2 SD covers **95.4%** of values. * Mean ± 3 SD covers **99.7%** of values. * **Limits of Normality:** In clinical medicine, the "normal range" for a lab test is typically defined as **Mean ± 2 SD** (encompassing 95% of the healthy population). * **Skewness:** If the tail is longer on the right, it is **Positively Skewed** (Mean > Median > Mode). If the tail is longer on the left, it is **Negatively Skewed** (Mode > Median > Mean).

Q: If the probability of full recovery following polio is 0.3 and the probability of partial recovery is 0.4, what is the total probability of full or partial recovery following polio?

0.7. ### Explanation This question tests the application of the **Addition Rule of Probability** in biostatistics. **1. Why Option B is Correct:** In probability theory, when two events are **mutually exclusive** (meaning they cannot occur at the same time), the probability of either event occurring is the sum of their individual probabilities. * **Event A (Full Recovery):** $P(A) = 0.3$ * **Event B (Partial Recovery):** $P(B) = 0.4$ Since a patient cannot simultaneously have a "full recovery" and a "partial recovery" from the same episode of polio, these are mutually exclusive events. To find the probability of "Full **OR** Partial Recovery," we use the formula: $$P(A \cup B) = P(A) + P(B)$$ $$0.3 + 0.4 = \mathbf{0.7}$$ **2. Why Other Options are Incorrect:** * **Option A (0.12):** This is the result of the **Multiplication Rule** ($0.3 \times 0.4$). This rule is used for independent events occurring simultaneously (Event A **AND** Event B), which is not applicable here. * **Option C (1.2):** Probability can never exceed **1.0**. Any value greater than 1 is mathematically impossible in biostatistics. * **Option D (0.1):** This is the result of subtraction ($0.4 - 0.3$), which has no relevance to the "OR" logic required by the question. **3. NEET-PG Clinical Pearls:** * **Mutually Exclusive Events:** Use the **Addition Rule** (Sum). * **Independent Events:** Use the **Multiplication Rule** (Product). * **Complementary Event:** The probability of "No Recovery" in this scenario would be $1 - 0.7 = 0.3$. * **Polio Fact:** In clinical practice, approximately 1% of polio infections lead to irreversible paralysis (usually asymmetric), while the majority are asymptomatic or mild.

Q: Which one of the following statements regarding pre-post clinical trials is most appropriate?

They use the patient as his or her own control. ### Explanation **Concept Overview** A **Pre-Post Clinical Trial** (also known as a "Before-and-After" study) is a type of quasi-experimental design where measurements are taken from the same group of participants both before and after an intervention. **Why Option C is Correct** The defining feature of this study design is that **the patient serves as his or her own control**. By comparing the baseline status (pre-intervention) to the outcome (post-intervention) in the same individual, researchers can minimize the impact of "between-subject" variability (confounding factors like genetics, age, or socioeconomic status), as these remain constant within the individual. **Analysis of Incorrect Options** * **Option A:** While many pre-post studies are non-randomized, they **can be randomized** (e.g., a Crossover Trial is a specialized randomized pre-post design where the order of treatments is randomized). * **Option B:** They are **not ideal for mortality studies**. Mortality is a "one-time" terminal event; once a patient dies, you cannot measure a "post-intervention" state or return them to baseline. These studies are better suited for chronic, stable conditions (e.g., hypertension, asthma). * **Option D:** They are actually **harder to interpret** than parallel trials. They are susceptible to "temporal effects" (natural recovery over time), "regression to the mean," and "carry-over effects" where the first phase influences the second. **High-Yield Pearls for NEET-PG** * **Crossover Design:** A specific type of pre-post trial that includes a **Washout Period** to eliminate the carry-over effect of the first drug. * **Advantage:** Requires a **smaller sample size** than parallel trials to achieve the same statistical power because individual variation is reduced. * **Limitation:** Not suitable for diseases that are cured by the intervention or for conditions that fluctuate rapidly.

Q: The probability of a person with a positive test result actually having the disease is given by which of the following?

Positive predictive value. **Explanation:** The correct answer is **Positive Predictive Value (PPV)**. This concept is fundamental to clinical decision-making as it determines the clinical significance of a test result for an individual patient. **1. Why Positive Predictive Value is correct:** PPV is defined as the probability that a person actually has the disease given that their test result is positive. It is calculated as: $$PPV = \frac{\text{True Positives (TP)}}{\text{Total Test Positives (TP + FP)}} \times 100$$ While sensitivity and specificity are inherent properties of a test, PPV is highly dependent on the **prevalence** of the disease in the population being tested. **2. Why other options are incorrect:** * **Negative Predictive Value (NPV):** This is the probability that a person is truly healthy given a negative test result. * **Sensitivity:** This measures the test's ability to correctly identify those *with* the disease (True Positive Rate). It is calculated among those who are already known to be diseased. * **Specificity:** This measures the test's ability to correctly identify those *without* the disease (True Negative Rate). It is calculated among those known to be healthy. **3. NEET-PG High-Yield Pearls:** * **Prevalence Relationship:** If the prevalence of a disease increases, the **PPV increases** and the **NPV decreases**. Sensitivity and Specificity remain unchanged. * **Screening vs. Diagnosis:** High sensitivity tests are preferred for **screening** (to "rule out" disease - SnNout), while high specificity tests are preferred for **confirmatory diagnosis** (to "rule in" disease - SpPin). * **Formula Tip:** Predictive values are the "horizontal" calculations in a 2x2 contingency table, whereas sensitivity/specificity are "vertical" calculations.

Q: Which of the following is the most commonly repeated factor in a dataset?

Mode. ### Explanation **Correct Answer: C. Mode** **Why Mode is the correct answer:** In biostatistics, the **Mode** is defined as the value that occurs with the highest frequency in a dataset. It represents the most "popular" or commonly repeated observation. In a frequency distribution curve, the mode corresponds to the highest peak. It is the only measure of central tendency that can be used for nominal (categorical) data (e.g., determining the most common blood group in a population). **Analysis of Incorrect Options:** * **A. Mean:** This is the arithmetic average calculated by summing all observations and dividing by the total number ($n$). It is sensitive to extreme values (outliers) and does not necessarily represent a repeated value. * **B. Median:** This is the middle-most value when data is arranged in ascending or descending order. It divides the distribution into two equal halves but does not indicate frequency of repetition. * **D. Standard Deviation:** This is a measure of **dispersion**, not central tendency. It quantifies how much the scores deviate from the mean. **High-Yield Clinical Pearls for NEET-PG:** * **Relationship in Normal Distribution:** Mean = Median = Mode (Symmetrical bell-shaped curve). * **Skewed Distributions:** * **Positively Skewed (Right tail):** Mean > Median > Mode. * **Negatively Skewed (Left tail):** Mode > Median > Mean. * **Relationship Formula:** $Mode = (3 \times Median) - (2 \times Mean)$. * **Best Measure of Central Tendency:** * For **Normal distribution**: Mean. * For **Skewed distribution**: Median. * For **Qualitative data**: Mode.

Q: What does the reliability of a screening test NOT mean?

Validity. ### Explanation In biostatistics, **Reliability** and **Validity** are two distinct pillars used to evaluate the quality of a screening or diagnostic test. **Why "Validity" is the correct answer:** Reliability refers to the **consistency** of a test—the ability of a method to yield the same results upon repeated measurements under the same conditions. **Validity**, on the other hand, refers to **accuracy**—the ability of a test to measure what it is actually intended to measure (i.e., how close the result is to the "True" value or Gold Standard). A test can be highly reliable (giving the same wrong result every time) without being valid. **Analysis of Incorrect Options:** * **A. Reproducibility:** This is a synonym for reliability. It refers to the ability of different observers to get the same results using the same test. * **B. Repeatability:** This is another synonym for reliability. It refers to the consistency of results when the same observer performs the test multiple times on the same subject. * **D. Precision:** In medical statistics, precision is the degree to which repeated measurements show the same results. It is the technical term for reliability. **High-Yield Clinical Pearls for NEET-PG:** 1. **Reliability = Precision = Consistency.** It is influenced by **Random Error**. 2. **Validity = Accuracy.** It is influenced by **Systematic Error (Bias)**. 3. **Components of Validity:** Sensitivity and Specificity are the primary measures of a test's validity. 4. **The Bullseye Analogy:** * Hits clustered together but far from the center = Reliable but not Valid. * Hits scattered but averaging at the center = Valid but not Reliable. * Hits clustered tightly in the center = Both Reliable and Valid.

Q: Calculate the specificity of the screening test based on the following results: | Screening test results | Diseased | Not diseased | Total | |---|---|---|---| | Positive | 400 | 200 | 600 | | Negative | 100 | 600 | 700 | | Total | 500 | 800 | 1300 |

75 percent. ### Explanation **1. Understanding the Correct Answer (B: 75 percent)** Specificity is the ability of a screening test to correctly identify those **without** the disease (True Negatives). It is calculated using the formula: $$\text{Specificity} = \frac{\text{True Negatives (TN)}}{\text{Total Non-diseased}} \times 100$$ From the given table: * **True Negatives (TN):** 600 (Those who tested negative and do not have the disease) * **Total Non-diseased:** 800 (The sum of False Positives and True Negatives) **Calculation:** $$\text{Specificity} = \frac{600}{800} \times 100 = \frac{3}{4} \times 100 = \mathbf{75\%}$$ Thus, the test correctly identifies 75% of healthy individuals as negative. **2. Analysis of Incorrect Options** * **A (70%):** This value does not correspond to any standard diagnostic metric in this table. * **C (80%):** This is the **Sensitivity** of the test. Sensitivity = True Positives (400) / Total Diseased (500) × 100 = 80%. It measures the ability to detect the disease in those who have it. * **D (85%):** This value is mathematically unrelated to the primary metrics (Sensitivity, Specificity, PPV, or NPV) derived from this data. **3. Clinical Pearls & High-Yield Facts for NEET-PG** * **SNOUT:** **S**ensitivity rules **OUT** (High sensitivity is ideal for screening tests to ensure no cases are missed). * **SPIN:** **S**pecificity rules **IN** (High specificity is ideal for confirmatory tests to avoid false positives). * **Prevalence Impact:** Sensitivity and Specificity are inherent properties of a test and do **not** change with disease prevalence. However, Predictive Values (PPV/NPV) are highly dependent on prevalence. * **False Positive Rate:** This is calculated as (1 - Specificity). In this case, it would be 25%.

Q: What is the measure used to detect true positive cases?

Sensitivity. **Explanation:** **Sensitivity** is the ability of a screening or diagnostic test to correctly identify those **with the disease**. It represents the proportion of people who truly have the disease and test positive (True Positives). Mathematically, it is calculated as: `Sensitivity = [True Positives / (True Positives + False Negatives)] × 100` A highly sensitive test is used for screening because it ensures that very few cases are missed (low false negatives). **Analysis of Incorrect Options:** * **Specificity:** This measures the ability of a test to correctly identify those **without the disease** (True Negatives). It is used to "rule in" a diagnosis and minimize false positives. * **Positive Predictive Value (PPV):** This indicates the probability that a patient actually has the disease given that the test result is positive. It is highly dependent on the **prevalence** of the disease in the population. * **Negative Predictive Value (NPV):** This indicates the probability that a patient is truly healthy given that the test result is negative. **High-Yield Clinical Pearls for NEET-PG:** * **SNOUT:** A **S**ensitive test, when **N**egative, rules **OUT** the disease (ideal for screening). * **SPIN:** A **S**pecific test, when **P**ositive, rules **IN** the disease (ideal for confirmation). * **Prevalence Relationship:** If prevalence increases, **PPV increases** and **NPV decreases**. Sensitivity and Specificity are inherent properties of the test and do not change with prevalence. * **Screening vs. Diagnosis:** Screening tests require high sensitivity; confirmatory tests require high specificity.

Q: A doctor taking a history from a diabetes patient decides to use a chart to assess joint involvement. Which type of chart should be used?

Tree diagram. ### Explanation **Correct Answer: D. Tree diagram** **Why it is correct:** In clinical medicine, a **Tree Diagram** (also known as a decision tree or flow chart) is the most appropriate tool for history taking and clinical assessment. It represents a logical sequence of events or a branching algorithm. When assessing joint involvement in a diabetic patient, the doctor follows a step-by-step diagnostic pathway (e.g., *Is the joint pain acute or chronic?* → *If acute, is it monoarticular or polyarticular?*). This hierarchical structure helps in narrowing down differential diagnoses based on specific clinical findings. **Why other options are incorrect:** * **A. Pie Chart:** This is used to represent the **proportions or percentages** of a total at a single point in time (e.g., the percentage of diabetic patients with different types of complications). It cannot show a sequence of clinical assessment. * **B. Venn Diagram:** This is used to show **relationships and overlaps** between different sets of data (e.g., patients who have both diabetes and hypertension). It is not used for sequential history taking. * **C. Histogram:** This is used to represent the **frequency distribution of continuous quantitative data** (e.g., the distribution of HbA1c levels in a population). It requires a continuous X-axis, which is not applicable to a clinical history chart. **High-Yield Clinical Pearls for NEET-PG:** * **Tree Diagram:** Best for representing **conditional probabilities** and clinical algorithms. * **Bar Chart:** Best for **discrete/qualitative data** (e.g., number of cases in different cities). * **Line Diagram:** Best for showing **trends over time** (e.g., maternal mortality rate over a decade). * **Scatter Diagram:** Used to show the **correlation** between two continuous variables. * **Box Plot:** Best for showing the **median and quartiles** (dispersion) of data.

Question 1

A city has a population of 10000 with 500 diabetic patients. A new diagnostic test gives true positive results in 350 patients and false positive results in 1900 patients. Which of the following is/are true regarding the test?

Accepted Answer

All of the above

Answer

Prevalence is 5%

Answer

Sensitivity is 70%

Answer

Specificity is 80%

Question 2

Which of the following is NOT true about the normal response curve?

Accepted Answer

Standard deviation = 0

Answer

Bell shaped

Answer

Total area of curve = 1

Answer

Mean, mode, and median coincide

Question 3

If the probability of full recovery following polio is 0.3 and the probability of partial recovery is 0.4, what is the total probability of full or partial recovery following polio?

Accepted Answer

0.7

Answer

0.12

Answer

1.2

Answer

0.1

Question 4

Which one of the following statements regarding pre-post clinical trials is most appropriate?

Accepted Answer

They use the patient as his or her own control

Answer

They cannot be randomized

Answer

They are useful in studies involving mortality

Answer

They are usually easier to interpret than the comparable parallel clinical trial

Question 5

The probability of a person with a positive test result actually having the disease is given by which of the following?

Accepted Answer

Positive predictive value

Answer

Negative predictive value

Answer

Sensitivity

Answer

Specificity

Question 6

Which of the following is the most commonly repeated factor in a dataset?

Accepted Answer

Mode

Answer

Mean

Answer

Median

Answer

Standard deviation

Question 7

What does the reliability of a screening test NOT mean?

Accepted Answer

Validity

Answer

Reproducibility

Answer

Repeatability

Answer

Precision

Question 8

Calculate the specificity of the screening test based on the following results:

| Screening test results | Diseased | Not diseased | Total |
|---|---|---|---|
| Positive | 400 | 200 | 600 |
| Negative | 100 | 600 | 700 |
| Total | 500 | 800 | 1300 |

Accepted Answer

75 percent

Answer

70 percent

Answer

80 percent

Answer

85 percent

Question 9

What is the measure used to detect true positive cases?

Accepted Answer

Sensitivity

Answer

Specificity

Answer

Positive predictive value

Answer

Negative predictive value

Question 10

A doctor taking a history from a diabetes patient decides to use a chart to assess joint involvement. Which type of chart should be used?

Accepted Answer

Tree diagram

Answer

Pie chart

Answer

Venn diagram

Answer

Histogram

Biostatistics — MCQs

Biostatistics — MCQs

On this page

Practice by Chapter

Want unlimited practice?